Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sucheta Telang

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|April 23, 2005
Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethalityJason Chesney, Sucheta Telang, Abdullah Yalcin, et al.
Virology Journal|June 30, 2007
Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primersAmy L Clem, Jonathan Sims, Sucheta Telang, et al.
American Journal of Perinatology|October 10, 2024
Evaluating Nutritional Selection and Outcomes in Neonatal Abstinence Syndrome: A Retrospective ReviewJuan A Gallegos, Laura Serke, Yana Feygin, et al.
Oncotarget|August 14, 2014
Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growthJason Chesney, Jennifer Clark, Alden C Klarer, et al.
Melanoma Research|March 22, 2018
Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitorsJason Chesney, Yoannis Imbert-Fernandez, Sucheta Telang, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 10, 2020
A quality improvement project improving the value of iNO utilization in preterm and term infantsHannah Fischer, Tamina Singh, Lori Devlin, et al.
Journal of the American Dietetic Association|September 27, 2005
Fortifying fresh human milk with commercial powdered human milk fortifiers does not affect bacterial growth during 6 hours at room temperatureSucheta Telang, Carol Lynn Berseth, Paul W Ferguson, et al.
Breast Cancer Research and Treatment|September 11, 2016
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancerJulie O'Neal, Amy Clem, Lindsey Reynolds, et al.
Journal of Translational Medicine|May 18, 2012
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activationSucheta Telang, Brian F Clem, Alden C Klarer, et al.
Cancers|July 13, 2024
Genomic Deletion of PFKFB3 Decreases In Vivo TumorigenesisYoannis Imbert-Fernandez, Simone M Chang, Lilibeth Lanceta, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|April 23, 2005
Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethalityJason Chesney, Sucheta Telang, Abdullah Yalcin, et al.
Virology Journal|June 30, 2007
Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primersAmy L Clem, Jonathan Sims, Sucheta Telang, et al.
American Journal of Perinatology|October 10, 2024
Evaluating Nutritional Selection and Outcomes in Neonatal Abstinence Syndrome: A Retrospective ReviewJuan A Gallegos, Laura Serke, Yana Feygin, et al.
Oncotarget|August 14, 2014
Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growthJason Chesney, Jennifer Clark, Alden C Klarer, et al.
Melanoma Research|March 22, 2018
Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitorsJason Chesney, Yoannis Imbert-Fernandez, Sucheta Telang, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 10, 2020
A quality improvement project improving the value of iNO utilization in preterm and term infantsHannah Fischer, Tamina Singh, Lori Devlin, et al.
Journal of the American Dietetic Association|September 27, 2005
Fortifying fresh human milk with commercial powdered human milk fortifiers does not affect bacterial growth during 6 hours at room temperatureSucheta Telang, Carol Lynn Berseth, Paul W Ferguson, et al.
Breast Cancer Research and Treatment|September 11, 2016
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancerJulie O'Neal, Amy Clem, Lindsey Reynolds, et al.
Journal of Translational Medicine|May 18, 2012
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activationSucheta Telang, Brian F Clem, Alden C Klarer, et al.
Cancers|July 13, 2024
Genomic Deletion of PFKFB3 Decreases In Vivo TumorigenesisYoannis Imbert-Fernandez, Simone M Chang, Lilibeth Lanceta, et al.
Pageof 5